ABSTRACT
INTRODUCTION
Both Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are acute dermatologic diseases characterized by purpuric macules and targetoid lesions with full thickness epidermal necrosis histologically. However, in SJS, there is detachment of up to 10% of the cutaneous surface with mucous membrane involvement, whereas in TEN more than 30% of the cutaneous surface is involved, also with mucous membrane involvement. Similar clinical and histological features with 10 to 30% skin detachment are called Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) overlap syndrome (1) . Medications are commonly implicated in the causation of SJS but infections such as mycoplasma and herpes simplex may also be culpable. In TEN, drugs are the commonest cause. When the area of denudation of the skin is less than 10% (SJS), the mortality rate is 1 to 5%. However when it is more than 30% (TEN), the mortality rate is between 25% and 35% and may approach 50% (2) . In all these syndromes, there may be significant involvement of oral, nasal, eye, vaginal, urethral, gastrointestinal and lower respiratory tract mucosa.
Erythema multiforme (EM) is a more benign condition with target and targetoid lesions usually in an acral distribution with involvement of less than 10% of the skin and commonly with oral involvement. Most cases are secondary to herpes simplex infection and recur with herpetic recurrences. Morbidity is low and there is no mortality. For a long time, SJS and TEN were thought to be part of a spectrum with EM but now some evidence suggests that EM may be a distinct entity (1, (3) (4) (5) .
Stevens-Johnson syndrome and TEN are often druginduced but the pathophysiologic mechanism is unknown. T cells, especially CD8 + lymphocytes have been posited to play an important role (6) . There also seems to be a genetic predisposition, especially in particular ethnic groups and for particular drugs. An association between the HLA-B*1502 allele and SJS/TEN due to carbamazepine, phenytoin and lamotrigine in Han Chinese in Hong Kong has been demonstrated (7). In Thailand, an association was found between HLA-B*5801 allele and allopurinol-induced SJS/TEN in both Asians and non-Asian populations (8) .
In the United States of America (USA), the incidence of TEN was reported to be 0.5 per million population per year according to one study (9) . In Germany, the incidence rates for SJS, SJS/TEN overlap and TEN are one to two cases per million population per year (10) .
Sepsis and respiratory distress are the most common causes of death. To assess the prognosis of patients with SJS/TEN, the severity of illness score of TEN (SCORTEN) is used (2, 11) . This scoring method takes into consideration important prognostic factors including age, the presence of underlying malignancy, heart rate, the percentage loss of body surface area, blood urea nitrogen, serum glucose level and bicarbonate level. Other negative prognostic factors are persistent neutropaenia, hypoalbuminaemia and persistent azotemia. After re-epithelialization, patients may have long term sequelae including corneal scarring, entropion of eyelashes, photophobia, watery or dry eyes, corneal and conjunctival neovascularization, all of which may lead to blindness. Lesions may heal with dyspigmentation, nails may grow abnormally and phimosis of the penis or vaginal synechiae may result.
Stevens-Johnson syndrome and TEN occur in all age groups, including children. However, both SJS and TEN occur more frequently in the older population. In one study, allopurinol was found to be the most common cause of SJS and TEN in Europe and Israel (12) . In a study in India, the common offending agents were antimicrobials and nonsteroidal anti-inflammatory drugs [NSAIDs] (13) . Overall, the most commonly cited drugs as causes of SJS and TEN are the anticonvulsants, sulphonamide antibiotics, NSAIDs and allopurinol (14) . In a study in the USA, aminopenicillins were frequently implicated in patients with SJS (15) . Among persons with human immunodeficiency virus (HIV), the commonest causes were nevirapine, cotrimoxazole, stavudine and clarithromycin (16) . The usual time between initiation of drug use and onset of SJS/TEN was two to eight weeks (17) .
In this study, the aim was to examine the frequency, aetiology and outcome of SJS/TEN among patients admitted to the dermatology ward at the University Hospital of the West Indies (UHWI), Jamaica.
SUBJECTS AND METHODS
Ethical approval was obtained from the University Hospital of the West Indies/University of the West Indies/Faculty of Medical Sciences Ethics Committee. The study was conducted retrospectively. The dermatology admissions recorded for a nine-year period, from January 1997 to December 2005, were reviewed. All patients who were admitted with a diagnosis of SJS, TEN or SJS/TEN overlap syndrome were included in the study. All diagnoses had been confirmed by skin biopsy. A data collection sheet was designed for the purpose of organizing the abstraction of data from patient records. Data included patient demographics, date and duration of admission to hospital and a detailed drug history including any previous episodes of drug sensitivity. All drugs reportedly ingested by the patients up to three months prior to their cutaneous reaction were documented and the period of time between drug ingestion and the appearance of skin lesions was also noted. Medication started within eight weeks of the onset of lesions was deemed most likely to have caused the eruption. Additionally, clinical diagnoses, co-morbidities, histopathological diagnoses, final outcome and all ensuing complications were noted. The data retrieved were collated and analysed using SPSS 12.0.
RESULTS
Two patients' records could not be located. Therefore, some data on these patients had to be obtained from other sources Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis such as histopathology request forms and ward admission records. During the nine-year period, there were a total of 959 dermatological admissions of which 101 were due to cutaneous drug reactions (CDRs). Twenty-one of these were SJS or TEN. Stevens-Johnson syndrome and TEN comprised 2.2% of all admissions and 21% of all CDRs admitted. There were 10 cases of SJS and 11 of TEN with no overlap syndrome. Two patients had a history of previous hypersensitivity to the drug implicated. Three of the TEN cases had died (27% of TEN cases) and unfortunately two of those medical records were the ones that could not be located. The cause of death in one case was renal failure.
The ages of patients with SJS and TEN ranged from 13 to 95 years with a mean age of 40.2 years. There were 10 females and 11 males with more males having TEN and more females having SJS (Fig. 1) . In one case, two drugs were implicated were hydantoin anticonvulsants (five cases), sulphonamide antibiotics (four cases), penicillins (four cases) and NSAIDS (three cases). When further divided into categories, antimicrobials were by far the most common cause with 13 cases (Fig. 2) . considered culpable as these were started during the same period. The drugs most commonly implicated were phenytoin in five cases, cotrimoxazole in four cases and amoxicillin/clavulanic acid in two cases (Table 1) . When drugs were divided into classes (Table 2) , the most common classes The period of hospitalization for survivors ranged from six to 71 days. The mean period of hospital admission was 21 days (three weeks). The most common complication was hepatic impairment in seven cases followed by renal impairment in four cases and conjunctivitis in three patients (Table 3 ). However, it should be noted that there were six patients with ophthalmic complications. By far, the most common referral to other specialties was made to ophthalmology (Table 4) .
significantly to morbidity and mortality on the dermatology ward. 
DISCUSSION
The findings in our study were consistent with those in previous studies in several respects. At the UHWI, the distribution of males and females was almost equal in SJS and TEN as in other surveys (10) . The list of most common causative agents identified were hydantoin anticonvulsants (22.7%), sulphonamide antibiotics (18.2%), penicillins (18.2%) and NSAIDS (13.6%). Although the drugs were similar, the frequencies differed from that found in a study in Togo which showed antibacterial sulphonamides (50.6%), nevirapine (23.6%), NSAIDs (5.6%) and anti-epileptic medications (3.4%) as the most commonly implicated drugs (18) . This may reflect the different prescribing practices of local medical practitioners in these two studies.
The range and number of complications and referrals highlight the need for a team approach to management and the requirement for early intervention especially by the ophthalmology service. It also underscores how much resources are utilized on these patients. The mortality rate in our study on TEN patients was 27% which is at the lower end of the range of mortality rates found in other studies (2) . The mortality rate in SJS cases was zero. These low mortality rates were not expected as our patients were not nursed in an intensive care unit or burns unit as is usually recommended due to lack of available beds. Instead, they were housed in the dermatology ward in an isolated area or room. However, dayto-day management was done by medical personnel trained in dermatological care with input from other specialties as appropriate.
The strength of this study is that it is the first to report data on Afro-Caribbean patients. The main limitation of this study was that it included only patients admitted to the dermatology ward and no data were collected on those who might have developed these reactions while on other wards including paediatrics. Prospective collaborative studies would be helpful in capturing this additional information.
In summary, SJS and TEN, though uncommon, use significant hospital resources for each patient and contribute
